Neoplasms

Digestive System Diseases

All Conditions

Colorectal Neoplasms

Intestinal Neoplasms

Gastrointestinal Neoplasms

Digestive System Neoplasms

Gastrointestinal Diseases

Colonic Diseases

Intestinal Diseases

Rectal Diseases

Providing to the general practitioners every four months a list of their patients who are eligible for colorectal cancer screening but did not proceed yet and were not excluded for medical reason

Eligible patients' paper-based reminder

Julien Le Breton, MD, MPH

Screening for ColoRectal Cancer (CRC) is widely recommended because of compelling evidence that it reduces mortality from CRC and that it's cost-effective. In France, there is a national CRC screening programme inviting people aged 50-74 years by mail to consult their General Practitioner (GP) for a free on charge Faecal Occult Blood test deliverance every two years. Participation is a key factor for the screening programs success. High levels of screening uptake and the continued participation to regular screening must be achieved and maintained in the targeted population if the enormous potential of CRC screening is to be realised. Screening rates of various international programs vary widely (20-52%) and the participation is insufficient in the most settings. Therefore, a better understanding of facilitating and hindering factors of patient participation can guide interventions to improve CRC screening rates. They include patients and physicians' factors. One issue is about GPs practice. GP involvement has been shown to improve the participation in the CRC screening. This study aims to assess the effectiveness of an intervention targeting GPs to increase patient participation in the CRC screening. Volunteer GPs will be randomly assigned to either the intervention group or to usual care (control group) and they will be followed one year. The intervention consists in providing every four months to the experimental group a list of their patients who are eligible but did not proceed yet to the screening. In both groups, patient participation in the screening will be measured at the end of the study.

General Practitioners (GP) Involvement in Colorectal Cancer (CRC) Screening

Effect of Eligible Patients Paper-based Reminder for General Practitioners on Colorectal Cancer Screening Participation

Patient's status with colorectal cancer screening program to 15th june 2011 with two modalities

1. Update: completion of Faecal Occult Blood test or exclusion for medical reason within the duration of the study (The medical exclusions of the program are a personal or family history of Colorectal cancer, Crohn's disease, hemorrhagic rectocolitis, or hereditary nonpolyposis colorectal cancer, a colonoscopy undergone in the 5 previous years or a Fecal Occult Blood test undergone in the 2 previous years)
2. Not update

Paris 12 Val de Marne University

MD, MPH

Decision Aid

Lyndal J Trevena, MBBS

Les Irwig, PhD

This project has been completed and consisted of a randomised trial of six tailored decision aids giving patients evidence-based information about faecal occult blood test screening for bowel cancer. 314 Australians aged between 50-74 years were recruited from five general practices and randomised to received either the tailored decision aid with age-gender and family history specific information and values clarification exercise or a standard government information sheet.

The decision aid significantly increased the proportion of people who were informed participants in the screening program.

ICIBS Trial - Improving Patient Information About Bowel Cancer Screening - a Decision Aid Trial

Randomized Controlled Trial of Patient Decision Aids for Faecal Occult Blood Test Screening

University of Sydney

Study title	NCT ID	Conditions	Interventions	Eligibility	Organization
General Practitioners (GP) Involvement in Colorectal Cancer (CRC) Screening	NCT01364454	Colorectal Canc...	Eligible patien...	50 Years - 74 Years	Paris 12 Val de Marne University
ICIBS Trial - Improving Patient Information About Bowel Cancer Screening - a Decision Aid Trial	NCT00148226	Colorectal Canc...	Decision Aid	50 Years - 74 Years	University of Sydney
General Practitioners (GP) Involvement in Colorectal Cancer (CRC) Screening	NCT01364454	Colorectal Canc...	Eligible patien...	50 Years - 74 Years	Paris 12 Val de Marne University

Spots Global Cancer Trial Database for faecal occult blood test